Cargando…
Pharmacological Interventions for Primary Psychodermatologic Disorders: An Evidence Mapping and Appraisal of Randomized Controlled Trials
BACKGROUND: The lack of clinical guidelines for the treatment of primary psychodermatologic disorders (PPDs) hinders the delivery of optimal care to patients. The review aimed to identify, appraise, and summarize the currently available evidence about the safety and effectiveness of pharmacological...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068402/ https://www.ncbi.nlm.nih.gov/pubmed/36802832 http://dx.doi.org/10.1177/12034754231155888 |
_version_ | 1785018660458332160 |
---|---|
author | Turk, Tarek Liu, Chaocheng Fujiwara, Esther Straube, Sebastian Hagtvedt, Reidar Dennett, Liz Abba-Aji, Adam Dytoc, Marlene |
author_facet | Turk, Tarek Liu, Chaocheng Fujiwara, Esther Straube, Sebastian Hagtvedt, Reidar Dennett, Liz Abba-Aji, Adam Dytoc, Marlene |
author_sort | Turk, Tarek |
collection | PubMed |
description | BACKGROUND: The lack of clinical guidelines for the treatment of primary psychodermatologic disorders (PPDs) hinders the delivery of optimal care to patients. The review aimed to identify, appraise, and summarize the currently available evidence about the safety and effectiveness of pharmacological management of PPDs through randomized controlled trials (RCTs). METHODS: The Preferred Reporting Items for Systematic Review and Meta-Analyses (PRIMSA) statement and the Global Evidence Mapping Initiative guidance were followed. Medline, Embase, PsycInfo, Cochrane and Scopus were searched, and two reviewers independently completed article review, data extraction, and quality assessment. RESULTS: Among 2618 unique studies, full texts of 83 were reviewed and 21 RCTs were included. Five PDDs were identified: trichotillomania (n = 12), pathologic skin picking (n = 5), nail biting (n = 2), delusional parasitosis (n = 1), and dermatitis from compulsive hand washing (n = 1). Seven different classes of medications were investigated: SSRIs (i.e., fluoxetine, sertraline, and citalopram), tricyclic antidepressants (i.e., clomipramine and desipramine), antipsychotics (i.e., olanzapine and pimozide), anticonvulsant (i.e., lamotrigine), N-acetylcysteine, inositol, and milk thistle. RCT-derived evidence supports the use of antidepressants in trichotillomania (sertraline and clomipramine), pathologic skin picking (fluoxetine), pathologic nail biting and dermatitis from compulsive hand washing (clomipramine or desipramine); antipsychotics in trichotillomania (olanzapine) and delusional parasitosis (pimozide); N-acetyl cysteine in trichotillomania and skin picking. CONCLUSION: Few pharmacotherapies for primary psychodermatologic disorders are assessed through controlled trials in the literature. This review serves as a roadmap for researchers and clinicians to reach informed decisions with current evidence, and to build on it to establish guidelines in the future. |
format | Online Article Text |
id | pubmed-10068402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-100684022023-04-04 Pharmacological Interventions for Primary Psychodermatologic Disorders: An Evidence Mapping and Appraisal of Randomized Controlled Trials Turk, Tarek Liu, Chaocheng Fujiwara, Esther Straube, Sebastian Hagtvedt, Reidar Dennett, Liz Abba-Aji, Adam Dytoc, Marlene J Cutan Med Surg Review Articles BACKGROUND: The lack of clinical guidelines for the treatment of primary psychodermatologic disorders (PPDs) hinders the delivery of optimal care to patients. The review aimed to identify, appraise, and summarize the currently available evidence about the safety and effectiveness of pharmacological management of PPDs through randomized controlled trials (RCTs). METHODS: The Preferred Reporting Items for Systematic Review and Meta-Analyses (PRIMSA) statement and the Global Evidence Mapping Initiative guidance were followed. Medline, Embase, PsycInfo, Cochrane and Scopus were searched, and two reviewers independently completed article review, data extraction, and quality assessment. RESULTS: Among 2618 unique studies, full texts of 83 were reviewed and 21 RCTs were included. Five PDDs were identified: trichotillomania (n = 12), pathologic skin picking (n = 5), nail biting (n = 2), delusional parasitosis (n = 1), and dermatitis from compulsive hand washing (n = 1). Seven different classes of medications were investigated: SSRIs (i.e., fluoxetine, sertraline, and citalopram), tricyclic antidepressants (i.e., clomipramine and desipramine), antipsychotics (i.e., olanzapine and pimozide), anticonvulsant (i.e., lamotrigine), N-acetylcysteine, inositol, and milk thistle. RCT-derived evidence supports the use of antidepressants in trichotillomania (sertraline and clomipramine), pathologic skin picking (fluoxetine), pathologic nail biting and dermatitis from compulsive hand washing (clomipramine or desipramine); antipsychotics in trichotillomania (olanzapine) and delusional parasitosis (pimozide); N-acetyl cysteine in trichotillomania and skin picking. CONCLUSION: Few pharmacotherapies for primary psychodermatologic disorders are assessed through controlled trials in the literature. This review serves as a roadmap for researchers and clinicians to reach informed decisions with current evidence, and to build on it to establish guidelines in the future. SAGE Publications 2023-02-20 /pmc/articles/PMC10068402/ /pubmed/36802832 http://dx.doi.org/10.1177/12034754231155888 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Articles Turk, Tarek Liu, Chaocheng Fujiwara, Esther Straube, Sebastian Hagtvedt, Reidar Dennett, Liz Abba-Aji, Adam Dytoc, Marlene Pharmacological Interventions for Primary Psychodermatologic Disorders: An Evidence Mapping and Appraisal of Randomized Controlled Trials |
title | Pharmacological Interventions for Primary Psychodermatologic
Disorders: An Evidence Mapping and Appraisal of Randomized Controlled
Trials |
title_full | Pharmacological Interventions for Primary Psychodermatologic
Disorders: An Evidence Mapping and Appraisal of Randomized Controlled
Trials |
title_fullStr | Pharmacological Interventions for Primary Psychodermatologic
Disorders: An Evidence Mapping and Appraisal of Randomized Controlled
Trials |
title_full_unstemmed | Pharmacological Interventions for Primary Psychodermatologic
Disorders: An Evidence Mapping and Appraisal of Randomized Controlled
Trials |
title_short | Pharmacological Interventions for Primary Psychodermatologic
Disorders: An Evidence Mapping and Appraisal of Randomized Controlled
Trials |
title_sort | pharmacological interventions for primary psychodermatologic
disorders: an evidence mapping and appraisal of randomized controlled
trials |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068402/ https://www.ncbi.nlm.nih.gov/pubmed/36802832 http://dx.doi.org/10.1177/12034754231155888 |
work_keys_str_mv | AT turktarek pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials AT liuchaocheng pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials AT fujiwaraesther pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials AT straubesebastian pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials AT hagtvedtreidar pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials AT dennettliz pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials AT abbaajiadam pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials AT dytocmarlene pharmacologicalinterventionsforprimarypsychodermatologicdisordersanevidencemappingandappraisalofrandomizedcontrolledtrials |